Herrin VE - Search Results

1

A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma.

Rahma OE, Ashtar E, Ibrahim R, Toubaji A, Gause B, Herrin VE, Linehan WM, Steinberg SM, Grollman F, Grimes G, Bernstein SA, Berzofsky JA, Khleif SN. Rahma OE, et al. Among authors: herrin ve. J Transl Med. 2010 Jan 28;8:8. doi: 10.1186/1479-5876-8-8. J Transl Med. 2010. PMID: 20109232 Free PMC article. Clinical Trial.

2

Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers.

Toubaji A, Achtar M, Provenzano M, Herrin VE, Behrens R, Hamilton M, Bernstein S, Venzon D, Gause B, Marincola F, Khleif SN. Toubaji A, et al. Among authors: herrin ve. Cancer Immunol Immunother. 2008 Sep;57(9):1413-20. doi: 10.1007/s00262-008-0477-6. Epub 2008 Feb 23. Cancer Immunol Immunother. 2008. PMID: 18297281 Free PMC article. Clinical Trial.

3

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.

Rahma OE, Ashtar E, Czystowska M, Szajnik ME, Wieckowski E, Bernstein S, Herrin VE, Shams MA, Steinberg SM, Merino M, Gooding W, Visus C, Deleo AB, Wolf JK, Bell JG, Berzofsky JA, Whiteside TL, Khleif SN. Rahma OE, et al. Among authors: herrin ve. Cancer Immunol Immunother. 2012 Mar;61(3):373-84. doi: 10.1007/s00262-011-1100-9. Epub 2011 Sep 17. Cancer Immunol Immunother. 2012. PMID: 21927947 Free PMC article. Clinical Trial.

4

Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer.

Rahma OE, Herrin VE, Ibrahim RA, Toubaji A, Bernstein S, Dakheel O, Steinberg SM, Abu Eid R, Mkrtichyan M, Berzofsky JA, Khleif SN. Rahma OE, et al. Among authors: herrin ve. J Transl Med. 2014 Dec 16;12:353. doi: 10.1186/s12967-014-0353-4. J Transl Med. 2014. PMID: 25510844 Free PMC article.

5

High-dose chemotherapy in ovarian carcinoma.

Herrin VE, Thigpen JT. Herrin VE, et al. Semin Oncol. 1999 Feb;26(1):99-105. Semin Oncol. 1999. PMID: 10073566 Review.

6

Chemotherapy for ovarian cancer: current concepts.

Herrin VE, Thigpen JT. Herrin VE, et al. Semin Surg Oncol. 1999 Oct-Nov;17(3):181-8. doi: 10.1002/(sici)1098-2388(199910/11)17:3<181::aid-ssu7>3.0.co;2-7. Semin Surg Oncol. 1999. PMID: 10504666 Review.

7

Decreasing rates of hospitalization for varicella among young adults.

Herrin VE, Gray GC. Herrin VE, et al. J Infect Dis. 1996 Oct;174(4):835-8. doi: 10.1093/infdis/174.4.835. J Infect Dis. 1996. PMID: 8843224

8

Bendamustine-Induced Acute Generalized Exanthematous Pustulosis Confirmed by Patch Testing.

Harber ID, Adams KV, Casamiquela K, Helms S, Benson BT, Herrin V. Harber ID, et al. Dermatitis. 2017 Jul/Aug;28(4):292-293. doi: 10.1097/DER.0000000000000302. Dermatitis. 2017. PMID: 28617679 No abstract available.

9

The effect of new duty hours on resident academic performance and adult resuscitation outcomes.

Pepper DJ, Schweinfurth M, Herrin VE. Pepper DJ, et al. Among authors: herrin ve. Am J Med. 2014 Apr;127(4):337-42. doi: 10.1016/j.amjmed.2013.12.007. Epub 2013 Dec 16. Am J Med. 2014. PMID: 24355355

10

Recurrent, transformed non-Hodgkin's lymphoma presenting as chiasmal syndrome with hyperprolactinemia and hypopituitarism.

Sumrall A, Herrin V. Sumrall A, et al. J Miss State Med Assoc. 2010 Feb;51(2):35-6. J Miss State Med Assoc. 2010. PMID: 20827870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters